resveratrol has been researched along with Leukemia, T-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erker, T; Goldhahn, K; Handler, N; Kloesch, B; Loebsch, S; Schmetterer, K; Steiner, G | 1 |
| Gajate, C; Mollinedo, F; Reis-Sobreiro, M | 1 |
| Chen, H; Li, T; Wang, W; Ye, L | 1 |
| Bernhard, D; Crazzolara, R; Csordas, A; Kofler, R; Schwaiger, W; Tinhofer, I | 1 |
4 other study(ies) available for resveratrol and Leukemia, T-Cell
| Article | Year |
|---|---|
Antiproliferative and Pro-apoptotic Activities of a Novel Resveratrol Prodrug Against Jurkat CD4+ T-Cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Leukemic; Humans; Interleukin-2; Jurkat Cells; Leukemia, T-Cell; Prodrugs; Promoter Regions, Genetic; Resveratrol; Stilbenes; Transfection | 2016 |
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Boronic Acids; Bortezomib; Caspase 10; Caspase 8; Cell Line, Tumor; Drug Synergism; fas Receptor; Fas-Associated Death Domain Protein; Flow Cytometry; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia, T-Cell; Membrane Microdomains; Microscopy, Confocal; Mitochondria; Multiple Myeloma; Phosphorylcholine; Pyrazines; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Evaluation of anti-leukemia effect of resveratrol by modulating STAT3 signaling.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Leukemic; Humans; Jurkat Cells; Leukemia, T-Cell; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes | 2010 |
Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells.
Topics: Antioxidants; Apoptosis; Artifacts; Cell Division; Colorimetry; Dose-Response Relationship, Drug; Electron Transport; Formazans; Growth Inhibitors; Histocytochemistry; Humans; Indicators and Reagents; Leukemia, T-Cell; Mitochondria; NAD; NADP; Organ Specificity; Oxidation-Reduction; Resveratrol; Stilbenes; Subcellular Fractions; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |